Submit a Manuscript to the Journal
Artificial Cells, Nanomedicine, and Biotechnology
For an Article Collection on
Nanomedicine in Metabolic Disorders: Exploring innovative nanotechnology-based approaches for the diagnosis and treatment of metabolic diseases
Manuscript deadline
Article collection guest advisor(s)
Dr. Muhammad Sajid Hamid Akash,
Government College University, Pakistan
sajidakash@gcuf.edu.pk
Dr. Kanwal Rehman,
The Women University, Pakistan
kanwalrehman@wum.edu.pk
Dr. Shagufta Kamal,
Government College University, Pakistan
shaguftakamal@gcuf.edu.pk
Nanomedicine in Metabolic Disorders: Exploring innovative nanotechnology-based approaches for the diagnosis and treatment of metabolic diseases
Nanomedicine in Metabolic Disorders focuses on the application of advanced nanotechnology to transform the diagnosis and treatment of metabolic diseases. This collection will highlight cutting-edge research that leverages nanoscale materials and devices to improve drug delivery, enhance diagnostic precision, and provide targeted therapeutic interventions. The integration of nanomedicine in this field represents a paradigm shift in our approach to managing complex metabolic conditions.
The importance of this research cannot be overstated, as metabolic disorders such as diabetes, obesity, and metabolic syndrome continue to rise globally, imposing significant health and economic burdens. Traditional methods often fall short in early diagnosis and effective treatment, leading to complications and reduced quality of life. Nanotechnology offers innovative solutions by enabling highly specific interactions at the molecular level, thereby improving treatment efficacy and reducing side effects. This has the potential to revolutionize clinical outcomes and provide personalized healthcare strategies for millions of patients.
This article collection invites submissions that explore a diverse range of topics, including novel nanocarriers for targeted drug delivery, nanoscale diagnostic platforms, smart biomaterials, and integrated theranostic systems that combine therapeutic and diagnostic capabilities. We welcome original research articles, comprehensive reviews, and case studies addressing both experimental and computational approaches that deepen our understanding of nanomaterial interactions with metabolic pathways. Contributions that present robust experimental evidence and innovative methodologies to enhance the management of metabolic disorders are particularly encouraged, as they will play a critical role in shaping the future of personalized medicine.
Please submit your manuscript on our website, using the discount code IANB-2026-C37284 for 10% off the advertised article processing charge.
Please contact Haoyang Yi (Commissioning Editor) at haoyang.yi@taylorandfrancis.com with any queries regarding this Article Collection.
Guest Advisor
Dr. Muhammad Sajid Hamid Akash
Dr. Akash earned his PhD in Pharmaceutical Analysis from Zhejiang University and has since built a robust research portfolio focused on nanomedicine, drug delivery systems, and the biochemical underpinnings of metabolic disorders. His innovative work in applying nanotechnology to enhance diagnostic and therapeutic strategies in metabolic and endocrine disorders continues to shape the field.
Dr. Kanwal Rehman
Dr. Kanwal Rehman is a distinguished researcher and academician in the field of pharmaceutical sciences with extensive experience in drug discovery and development. She currently serves as a senior faculty member, leading innovative research projects that integrate advanced analytical techniques with novel therapeutic strategies. Over the course of his career, Dr. Rehman has published numerous articles in high-impact journals, contributing significantly to both fundamental science and its practical applications. Her expertise and leadership have been recognized through various awards and research grants, underlining her commitment to excellence in scientific inquiry. In addition to her research achievements, Dr. Rehman is passionate about mentoring young scientists and fostering collaborative projects that bridge academia and industry.
Dr. Shagufta Kamal
Dr. Kamal’s research in enzymology spans several key areas, including enzyme kinetics, protein engineering, biosensing, and bioremediation. A notable achievement in her biosensing research is the development of an acetylcholinesterase (AChE) inhibition-based biosensor for the detection of arsenic, a breakthrough with significant implications for environmental monitoring and public health. Known for her rigorous scientific approach, innovative methodologies, and commitment to sustainability, Dr. Kamal continues to make impactful contributions to the field of biochemistry. Her work not only advances scientific understanding but also offers practical solutions to real-world problems, underscoring her dedication to creating a more sustainable future.
Benefits of publishing open access within Taylor & Francis
Global marketing and publicity, ensuring your research reaches the people you want it to.
Article Collections bring together the latest research on hot topics from influential researchers across the globe.
Rigorous peer review for every open access article.
Rapid online publication allowing you to share your work quickly.
Submission Instructions
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.